DNA Ginkgo Bioworks Holdings, Inc.: Rasio cepet

Ginkgo Bioworks Holdings (DNA) is implementing ESG principles by creating biodegradable alternatives to industrial chemicals and transitioning its laboratories to renewable energy sources. This price action chart on GURU.Markets captured the 4.68 metric. The business relies on cell programming, utilizing AI to accelerate microorganism synthesis and expand collaborations in the agricultural and biopharmaceutical sectors to reduce operating expenses.

This ratio determines the issuer's solvency by assessing the ability to cover short-term liabilities solely through cash and accounts receivable, excluding inventory. By analyzing the quick liquidity calculation, an investor can see the financial reserve of Ginkgo Bioworks Holdings (DNA), which is critical for maintaining the bioprogramming platform and ensuring a stable stream of royalties from microorganism development.